AI program for precision Type 2 diabetes prediction

Lundoch Diagnostics has developed an artificial intelligence (AI)-based computer program (LDT2D v. 210328) for individualized Type 2 diabetes prediction and risk assessment. By imputing patented blood biomarker measurements, the program predicts Type 2 diabetes 4 years or longer before diabetes onset.
 

Base on the risk analysis, the AI program will offer guidance on intervention, including diet, physical activity and so on.